Tags: Drug.

Remikiren is a renin inhibitor under development for the treatment of hypertension (high blood pressure). It was first developed by Hoffmann–La Roche in 1996.

Remikiren.svg
ATC prefix
C09
ATC suffix
XA01
CAS number
126222-34-2
DrugBank
DB00212
FDA UNII code
LC7FBL96A4
IUPAC name
(2S)-2-[(2R)-2-benzyl-3-(2-methylpropane-2-sulfonyl)propanamido]-N-[(2R3S4R)-1-cyclohexyl-4-cyclopropyl-34-dihydroxybutan-2-yl]-3-(1H-imidazol-4-yl)propanamide
PubChem
6324659

Loading...

This page contains content from the copyrighted Wikipedia article "Remikiren"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.